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'25I-insulin metabolism in ebronie renal failure treated by
renal transplantation. Total clearance rate (TCR), urinary
clearance rate (UCR) and metabolic clearance rate (MCR) of
'251-insulin were measured in patients with severe chronic renal
insufficiency and after renal transplantation. The methodology
involved the constant infusion (11.5 ng/kg/min) of mildly
iodinated '25I-insu]in (mean degree of iodination less than
0.2 atom/molecule), and the estimation of the plasma concen-
tration of labelled insulin by chromatoelectrophoresis. MCR
was decreased by about 50% in chronic renal insufficiency,
treated or not by hemodialysis. MCR did not change 36 to 72 hr
after transplantation but reached normal values 7 to 15 days
after transplantation. UCR of '251-insulin is sometimes increased
in some patients with a renal graft; even in those circumstances,
the UCR remains negligible and the MCR almost entirely
accounts for the TCR.
Métabolisme de l'insuline 125-I dans I 'insuffisance rénale
ehronique traitée par transplantation rénale. La clearance totale
(TCR), Ia clearance urinaire (UCR) et la clearance métabolique
(MCR) de l'insuline 125-I ont été mesurées chez des patients
atteints d'insuffisance rénale chronique grave et après trans-
plantation renale. De l'insuline faiblement iodée (degré moyen
d'iodation inférieur a 0,2 atomes/molécule) a été administrée
par perfusion continue (11,5 ng/kg/min). La concentration
plasmatique de I'insuline 125-I a été estimée par chromato-
électrophorése. La MCR était diminuée d'environ 5070 dans
l'insuffisance rénale chronique, traitée ou non par hémodialyse.
La MCR n'avait pas augmenté de valeur 36 a 72 h aprés ta
transplantation, par contre elle était redevenue normale 7 it 15
jours aprés Ia transplantation. L'LJCR de l'insuline 125-I était
parfois augmentée chea certains patients ayant subi Ia greffe
rénate; mitme dans ces circonstances, l'uCR de l'insuline 125-I
restait négligeable et la MCR rendait compte presque entiitrement
de Ia TCR.
We have shown previously [1] that the metabolic
clearance rate (MCR) of '251-insulin is markedly
reduced in patients with chronic renal insufficiency
and in anephric patients, and that the extent of the
reduction is comparable in the two groups. By those
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findings, we confirmed the role played by the kidney in
the metabolism of insulin and we demonstrated that
the kidneys have completely lost their ability to cata-
bolize insulin in severe chronic renal disease.
In the present work we have studied the effect of
renal transplantation on insulin metabolism. For that
purpose we have measured the total clearance rate
(TCR) of '25I-insulin at different intervals after renal
transplantation. In order to evaluate the contribution
of excretion to the TCR, we have also measured the
urinary clearance rate (UCR) of '251-insulin.
Methods
Patients. Seven patients were studied 36 to 72 hr after
renal homotransplantation and, ten others, 7 to 15
days after transplantation. All of the patients were
treated with prednisone and azathioprine.
Patients who underwent renal transplantation were
compared with normal subjects (seven individuals) and
with patients in the final stage of chronic renal
insufficiency (ten patients). Five of the ten patients in
the latter group were submitted to regular dialysis
treatment and the five others were studied shortly
before hemodialysis was begun.
Experimental protocol. The experimental protocol
has been described in detail in a preceding study [1].
We have used a pork insulin weakly labelled with
125f by an electrolytic method [2]. The specific activity
of labelled insulin ranged from 3.5 to 4 mCi/mg. In
this iodination method 125f is diluted with carrier
117J• According to Mancini, Rosa and Rossi [3], mean
iodination degree (1271 pIus 1211) is less than 0.2
atom/molecule, this preparation probably containing
16.5% of monoiodinated molecules and 837 of
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Table 1. Patients having undergone renal transplantation compared with normal subjects and patients with chronic renal insufficiency
Subject or Sex Age Weight Blood Blood
patient No. years kg urea creatinine
mg/IOU ml mg/lOU ml
GFR
mi/rn/n
TCR
mi/mm/kg
TCR
mi/rn/n
UCR
mi/mm
MCR
mi/mm
Normal subjects
M 41 74.0 17 1.0 92 9.2 680.8 1.4 679.4
2 M 49 62.5 20 1.0 104 9.9 618.8 3.1 615.7
3 M 31 56.7 20 0.9 152 8.7 493.3 1.2 492.1
4 F 26 57.2 30 1.0 130 9.1 520.5 0.9 519.6
5 M 18 63.0 14 1.5 96 11.9 749.7 1.5 748.2
6 F 63 49.5 14 0.8 76 2.4
7 M 36 53.0 22 0.9 76 1.6
Mean±sEM 104± 11 9.8±0.2 612.6±48.1 1.7±0.3 611.0±48.0
Patients with chronic renal insufficiency
Before dialysis
8 F 38 61.6 282 17.0 3.4 209.4
9 M 32 77.6 360 23.8 4.1 318.2
10 M 23 77.0 189 10.2 5.5 423.5
11 F 40 58.5 165 11.1 5.8 339.3
12 F 34 53.6 124 19.7 6.3 337.7
Mean±sEM 5.0±0.6 325.6±34.3
After dialysis
Weeks
7 13 M 34 73.5 178 12.3 3.2 235.2
43 14 M 30 56.0 225 14.4 4.5 252.0
16 15 F 39 54.5 153 12.0 5.3 288.9
31 16 F 49 54.0 210 16.8 7.0 378.0
1 17 F 48 75.0 151 7.0 7.1 523.5
Mean±5EM 5.4±0.8 335.5±53.1
Mean of the ten patients studied before transplantation 5.2±0.4 330.6±29.8
Patients after transplantation
Hours
52 18 M 36 66.0 225 10.6 7 6.1 402.6
54 19 M 49 77.2 290 14.5 9 4.1 316.5
36 36 F 49 52.0 144 12.2 6 8.7 452.4
61 21 M 48 72.5 150 3.1 50 6.9 500.3
53 22 F 32 49.0 130 2.2 49 6.3 308.7
57 23 M 49 71.0 140 3.4 45 5.8 411.8
54 24 F 39 40.0 133 6.7 8 4.8 172.0
Mean±sEM 25±8 6.1±0.6 366.3±41.5
Days
11 25 M 32 70.0 42 1.2 75 11.5 805.0
9 26 M 23 61.7 44 0.7 61 13.0 802.1 20.4 781.7
9 27 M 24 72.7 144 2.0 30 8.3 o03.4 14.0 589.4
15 28 M 17 49.8 73 1.1 43 6.3 313.7 4.8 308.9
7 29 M 41 57.9 92 1.7 29 11.5 665.9 12.8 653.1
8 30 F 21 56.3 103 2.0 31 10.1 568.6 4.4 564.2
9 31 F 36 69.0 116 1.6 35 5.2 358.8 2.2 356.6
10 32 F 38 40.0 36 0.5 61 10.0 400.0 0.8 399.2
13 33 F 40 49.5 84 1.2 11.5 569.3
9 34 F 17 45.0 34 0.6 42 2.1
Mean±sEM 45±6 9.7±0.9 565.2±59.9 7.7±2.5 521.9±65.3
GFR, glomerular filtration rate; TCR, total clearance rate of 1251..insulin; UCR, urinary clearance rate of '251-insulin; MCR, meta-
bolic clearance rate of 1251-insulin.
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intact molecules. The biological activity of mono-
iodinated insulin is still a matter of controversy:
according to Freychet, Roth and Neville [4], it is
comparable to that of unlabelled insulin, but Arquilla,
Ooms and Mercola found its biological activity to be
attenuated [5]. However, '251-insulin has a metabolic
behavior closely similar to that of crystalline insulin as
far as the rate of catabolism [6] and binding to mem-
branes [7] are concerned. Therefore, it can be con-
sidered a valuable tool for the study of the fate of
insulin in various pathological conditions.
The infusion rate of labelled insulin was reduced to
one-half of that used in our preceding study (11.5
instead of 23 ng/kg/min) in order for a plateau to be
reached during the second hour of infusion in all
individuals (Fig. 1). One-sixth of the total dose
administered was given as a rapid injection preceding a
slow i.v. infusion that was maintained for about two
hours by means of a constant infusion pump (total
dose, 0.05 U/kg of body wt). Blood samples were
obtained every 20 mm. In normal subjects and in
patients with transplants of more than seven days, the
renal clearance of inulin and the '251-insulin UCR
were estimated simultaneously. For that purpose, three
to six urinary collections ranging from 20 to 40 mm in
duration were performed. The bladder was catheterized
in normal subjects but not in patients with renal
transplantation. In the latter patients, urinary speci-
mens were obtained by voluntary voiding under
abundant fluid intake. In transplanted patients at 36
to 72 hr, the UCR of '251-insulin was not measured, in
order to reduce the discomfort of the experiment, and
glomerular filtration rate (GFR) was estimated by the
24-hr clearance of endogenous creatinine.
We did not measure 1251-insulin UCR in patients
with advanced chronic renal failure, because the
absolute value of endogenous insulin UCR is less than
3 ml/min in that condition [8—12]. Previous studies in
several patients (unpublished data) have shown that
the UCR of 1251-insulin is also less than 3 mi/mm and,
therefore, negligible compared to the TCR.
Chemical determinations. Radioactivity correspond-
ing to intact 1251-insulin, damaged '251-insulin and
free 125J was measured in the infusate, blood and urine
by paper chromatoelectrophoresis [13]. Knowing the
efficiency of our well-type scintillator spectrometer for
125J and the specific activity of the '251-insulin pre-
paration, we were able to express the level of intact
'251-insulin in ng/ml. Chromatoelectrophoresis of the
urine was performed by mixing urine: sheep serum,
3: 1. The recovery of '251-insulin added to urine from
transplanted patients was comparable to the recovery
in normal subjects (97.3 3.8% SEM). Moreover,
recovery was not modified by pH changes in the range
of 5 to 8. No significant loss of urinary '251-insulin
due to adsorption to glass containers was observed
during brief periods of time. However, plasma of
the fasting patient (0.5 ml for 50 ml of urine) was
added to all urinary samples to prevent degradation
of 1251-insulin during storage.
inulin concentration was estimated by the method of
Roe et al [14] and urea and creatinine by routine
techniques using an autoanalyser (Technicon) [15, 16].
Measurement of the total clearance rate of 125J
insulin. TCR of '251-insulin represents the fraction of
insulin space cleared from its '251-insulin per unit of
time. TCR includes the amount of '251-insulin meta-
bolized by the tissues (MCR) and that excreted in the
urine (UCR). In all the normal subjects and in all the
patients, '251-insulin values in plasma reached a
plateau within two hours after the onset of the
infusion (Fig. 1). At that time, the amount of 125J..
insulin leaving its diffusion space equals the quantity
infused. TCR can be calculated as the ratio between
the amount of 1251-insulin infused and the '251-insulin
concentration at the plateau. MCR can be obtained
by subtracting the UCR from the TCR. Statistical
calculations were conducted according to variance
analysis [17].
Results
Total clearance rate (Table 1 and Fig. 2). Mean
TCR was 9.8 ml/min/kg in the normal subjects.
In patients with chronic renal insufficiency who
were not treated by hemodialysis, the mean TCR was
5.0 mI/mm/kg. In those who were treated by dialysis,
1251..insulifl infusion, 11.5 ng/kg mm
36—72 hr after transplantation
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Fig. 1. Evolution of the mean plasma concentration in '251-insulin
during constant 125f infusion in the four groups studied.
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Fig. 2. Total clearance rate (TCR) of 1251-insulin in the four
groups studied.
the mean TCR was 5.4 mI/mm/kg. The difference
between the two values was not statistically significant;
hence, all patients with chronic renal insufficiency
have been pooled in one group. Mean TCR was
significantly lower in this group (5.2 mI/mm/kg) than
in normal subjects (P<O.OOl).
In patients who had received a transplanted kidney
for 36 to 72 hr, mean TCR (6.1 mI/mm/kg) was less
than that observed in normal subjects (P<O.OOl).
However, it did not differ significantly from that of
patients with chronic nephropathy before trans-
plantation.
In patients grafted for 7 to 15 days, the mean TCR
(9.7 mI/mm/kg) was higher than in patients with
chronic renal insufficiency (P<O.OOl) and it did not
differ from that observed in normal subjects.
Mean GFR was 25 mI/mm in the group studied at
36 and 72 hr after transplantation and 45 mI/mm in
the group studied at 7 to 15 days after transplantation.
No correlation between GFR and TCR was observed
for either (P>O.05).
Urinary clearance rate (Table I and Fig. 3). Mean
UCR was 1.7 mI/mm in normal subjects. The scatter
of the observations was great in patients who had been
grafted for 7 to 15 days; the UCR was normal in some
patients and markedly increased in others.
Metabolic clearance rate (Table 1). In normal
subjects and in patients with chronic renal insuffi-
ciency, the MCR was almost equivalent to the TCR,
absolute values of 1251-insulin UCR being very low.
20 -
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Fig. 3. Urinary clearance rate (UCR) of 1251-insulin in control
subjects and in patients 7 to 15 days after transplantation.
Equivalence of TCR and MCR could not be esta-
blished in patients grafted for 36 to 72 hr since the
UCR of '251-insulin was not measured.
In patients grafted for more than seven days, the
MCR was only slightly different from the TCR.
Indeed, even when the UCR of 1251-insulin was high,
as in patient 26, it accounted for about 2.5% of TCR.
Discussion
Under the present experimental conditions, the
mean TCR of 1251-insulin in normal subjects is higher
than that which we have observed in previous studies
(5.6 mI/mm/kg) [1]. The difference is probably due to
the fact that in the current study we have infused one-
half the '251-insulin dose used before, in order to reach
a plateau in all cases. It has been well demonstrated
in dogs [6], and recently in man [18], that the TCR
decreases with increasing blood concentrations of
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'251-insulin, probably because the capacity of the liver
to catabolize 1251-insulin is progressively saturated
[19]. However, there may also be a species-difference
in insulin metabolism since in the rat the total clearance
rate of insulin is independent of plasma insulin
concentrations [20].
The decrease in the TCR of '251-insulin in chronic
renal insufficiency was about 50%. This reduction was
the same in patients with severe chronic renal in-
sufficiency before the first hemodialysis and in patients
whose uremic state had been improved by maintenance
dialysis. These results confirm those of O'Brien and
Sharpe [21]. They show that metabolic disorders
associated with nitrogen retention cannot be the main
cause of the diminution of insulin TCR and emphasize
once more the role of the kidney in insulin metabolism.
The renal metabolism of 1251-insulin is still very
much altered 36 to 72 hr after transplantation. Since
some of our patients had attained a satisfactory rate
of glomerular filtration at that time, it appears that the
glomerular function of the renal graft can be restored
before that of the tubular function which is responsible
for the catabolism of 1251-insulin.
In patients grafted for 7 to 15 days, catabolism of
'251-insulin is usually normal. On the contrary, GFR
is very often reduced. One may be surprised that the
metabolic clearance rate of '251-insulin is the same in
one renal graft with a low GFR as in two normal kid-
neys. It has been shown, however, in healthy donors
that the slope of the 1311-insulin disappearance curve is
not modified by unilateral nephrectomy two weeks
after the operation, in spite of a reduction of GFR [21].
The lack of correlation between GFR and MCR
would be surprising if glomerular filtration was the
only way for insulin to reach the proximal tubule.
Autoradiography has clearly shown the transfer of
labelled insulin through the glomeruli and its sub-
sequent concentration within the cells of the proximal
convoluted tubules [22, 23]. However, the renal
clearance of insulin in man, as estimated by measuring
the renal blood flow and the renal arteriovenous
difference of insulin, is much higher than the GFR
Eli, 12]. In dogs [24], as in rats [20], ligature of the
ureter does not abolish the renal arteriovenous differ-
ence of insulin, in spite of suppression of glomerular
filtration. Thus, it is highly probable that insulin can
enter the tubule cells from the peritubular capillaries.
Low filtration rate is therefore compatible with normal
insulin metabolism by the kidney.
The increase in the UCR of '251-insulin observed in
some patients with a renal graft probably indicates a
reduction in the tubular reabsorption of insulin. A
tubular defect is also suggested by the frequent
occurrence of a "tubular" type of proteinuria two
weeks after transplantation [25, 26]. It must be noted,
however, that the UCR of 1251-insulin, even when high,
remains a negligible part of TCR. Thus, restoration of a
normal TCR after transplantation is due essentially to
the metabolic action of the kidney and not to any
increased urinary loss.
The possibility that postoperative therapy may
influence the metabolism and the urinary excretion of
'251-insulin cannot be disregarded. The effect of hydro-
cortisone-like substances on protein metabolism is
well known, but the influence of prednisone admini-
stration on '251-insulin metabolism has not been
studied systematically. Elgee and Williams have not
seen increased '311-insulin catabolism by the liver,
kidneys or muscles of animals treated with hydro-
cortisone [27]. On the other hand, there is no reason
to believe that immunosuppressive therapy has any
action on the metabolism or on the urinary excretion
of insulin.
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